News

Collaboration between dermatologists and gynecologists can improve patient quality of life and outcomes in vSCC treatment.

Google Search data analyzed from September 2021 to September 2022 revealed what patients are searching for and the findings may surprise you.

All participants saw an improvement in skin appearance and texture after treatment.

After a minimum 7-day vacation, participants with the highest ultraviolet radiation exposure experienced a decrease in Proteobacteria.

Timber Pharmaceuticals has been developing TMB-001 for the treatment of congenital ichthyosis.

This Psoriasis Awareness Month, let us know your experiences. Click here to answer this week's poll.

According to study authors, this electrical communication between skin cells may have the potential for therapeutic implications.

Although rare, clinicians are encountering more pediatric patients who are at an increased risk of skin cancer due to immunosuppression.

In part 3 of this Frontline Forum series, James Del Rosso, DO; Hilary Baldwin, MD; Neal Bhatia, MD; Christopher Bunick, MD, PhD; and Leon Kircik, MD, discuss the use of clascoterone cream 1%, differences in isotretinoin formulations, targeting sebum production, acne guidelines for patient care, and more.

When children present with nodules, several diagnoses should be considered, including pilomatricoma, vascular tumors, and fibrous tumors.

Acne was mild to moderate in severity and successfully managed with topical or oral treatments.

Keep up with the latest headlines in dermatology from the past week, including the use of skin allografts in treating victims of the Maui wildfires and ways to help victims, and more.

ICYMI, this week we had stories about counting down to Fall Clinical in Vegas, clascoterone cream 1% for acne vulgaris management, VP-315 for basal cell carcinoma lesions, and more.

Patient and physician demographics were not significantly associated with discordance.

Following this week's Science of Skin media roundtable hosted by AbbVie, panelist and National Psoriasis Foundations President and CEO Leah Howard, JD, discusses the importance of advocacy and mental health in chronic skin conditions.

David Mandell, JD, MBA, is here to help ensure new and novice clinicians understand the impact of taxes, lifestyle creep, investment plans, and more.

A combined treatment regimen of encorafenib and binimetinib led to improved progression-free survival, overall response rate, and tolerability in patients with advanced BRAF-mutant melanoma.

UV exposure or trauma to the skin, such as blistering and ulceration, can lead to changes in skin pigmentation and appearance. 

Total dose and number of cycles of rituximab were not associated with duration or severity of COVID-19 disease.

Patients with the DecisionDx-Melanoma 31-gene expression profile test had a 29% lower melanoma-specific survival mortality.

The DERMACLEAR study has retrospectively obtained data from more than 54,000 patients, and the NLP system had greater than 95% precision.

Following this week's Science of Skin media roundtable hosted by AbbVie, panelist and dual-board certified dermatologist and psychiatrist Evan Rieder, MD, discusses the relationship between chronic skin conditions and mental health.

In this month's Legal Eagle, learn what clinicians are required to disclose about their personal health ahead of performing procedures.

A Zurich case series is demonstrating the efficacy of dupilumab injections in patients with inflammation and chronic prurigo.

ABO blood type appeared to be a factor in severity of acne vulgaris.

Most of the patients receiving the non-surgical treatment experienced a complete clearing of tumors.

Researchers found that STAT3 could be activated, and inhibition could be achieved in patients with hypertrophic scarring.

While the linkage between squamous cell cancers and genital lichen sclerosus has been well-established, fewer studies have examined the associations between penile melanomas in males.

In this week’s Pointers With Portela, the 208SkinDoc answers frequently asked questions about microneedling and its benefits.

This Psoriasis Awareness Month, Dermatology Times is looking back at the treatment and research landscape of 2023.